Consolidated Statement of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total		Common Stock	Paid-in capital	Noncontrolling interest	Retained earnings	Treasury stock	AOCI Including Portion Attributable to Noncontrolling Interest [Member]
Stockholders' Equity Attributable to Noncontrolling Interest					$ 9,721
Total stockholders’ equity	$ 1,218,621
Beginning Balance at Feb. 02, 2019			$ 1,033	$ 405,379		$ 2,418,544	$ (1,513,604)	$ (102,452)
Beginning balance, shares outstanding at Feb. 02, 2019			66,227				37,073
Effect on Unearned Revenue Liabilities from New Accounting Principal in Period of Adoption	(75,165)
Net income attributable to noncontrolling interests	5,602
Net income attributable to A&F	39,358					39,358
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	44,960
Purchase of common stock	(63,542)
Purchase of common stock, shares			3,957				3,957
Dividends	(51,510)					(51,510)
Share-based compensation issuances and exercises	(6,804)	[1]		(14,403)		(17,482)	$ (25,081)
Share-based compensation issuances and exercises, shares			(516)				(516)
Share-based compensation expense	14,007			14,007
Derivative financial instruments, net of tax	(1,354)							(1,354)
Foreign currency translation adjustments, net of tax	(5,080)							(5,080)
Distributions to noncontrolling interests, net	$ (2,955)				(2,955)
Ending Balance at Feb. 01, 2020			$ 1,033	404,983		2,313,745	$ (1,552,065)	(108,886)
Ending balance, shares outstanding at Feb. 01, 2020			62,786				40,514
Common stock, dividends declared (in dollars per share)	$ 0.80
Stockholders' Equity Attributable to Noncontrolling Interest					12,368
Total stockholders’ equity	$ 1,071,178
Net income attributable to noncontrolling interests	5,067
Net income attributable to A&F	(114,021)					(114,021)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	(108,954)
Purchase of common stock	$ (15,172)
Purchase of common stock, shares	15,172		1,397				1,397
Dividends	$ (12,556)					(12,556)
Share-based compensation issuances and exercises	(5,694)	[1]		(22,382)		(37,698)	$ (54,386)
Share-based compensation issuances and exercises, shares			(1,010)				(1,010)
Share-based compensation expense	18,682			18,682
Derivative financial instruments, net of tax	(5,616)							(5,616)
Foreign currency translation adjustments, net of tax	12,195							12,195
Distributions to noncontrolling interests, net	(4,751)				(4,751)
Ending Balance at Jan. 30, 2021	$ 936,628		$ 1,033	401,283		2,149,470	$ (1,512,851)	(102,307)
Ending balance, shares outstanding at Jan. 30, 2021			62,399				40,901
Common stock, dividends declared (in dollars per share)	$ 0.28
Stockholders' Equity Attributable to Noncontrolling Interest	$ 12,684				12,684
Total stockholders’ equity	949,312
Net income attributable to noncontrolling interests	7,056
Net income attributable to A&F						263,010
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	270,066
Purchase of common stock	(377,290)
Purchase of common stock, shares			10,200				10,200
Dividends	0					0
Share-based compensation issuances and exercises	(13,163)	[1]		(17,397)		(26,324)	$ (30,558)
Share-based compensation issuances and exercises, shares			(786)				(786)
Share-based compensation expense	29,304
Derivative financial instruments, net of tax	10,518
Foreign currency translation adjustments, net of tax	(22,917)
Distributions to noncontrolling interests, net	(8,506)				(8,506)
Ending Balance at Jan. 29, 2022	$ 826,090		$ 1,033	$ 413,190		$ 2,386,156	$ (1,859,583)	$ (114,706)
Ending balance, shares outstanding at Jan. 29, 2022			52,985				50,315
Common stock, dividends declared (in dollars per share)	$ 0.00
Stockholders' Equity Attributable to Noncontrolling Interest	$ 11,234				$ 11,234
Total stockholders’ equity	$ 837,324

[1] (1)    Classified within other financing activities on the Consolidated Statements of Cash Flows.